PMC:2265677 / 774-1090 JSON TXT

Magnesium treatment in alcoholics: a randomized clinical trial Correction After publication of our work [1], we noticed that the magnesium (Mg) content of the trial tablets was inadvertently given as 250 mg. The correct content was 200 mg. Thus the first sentence under the subtitle "Intervention" should read: The patients received orally for 8 weeks either a daily dose of 400 mg of Mg tablets divided in two tablets (200 mg each) or matching placebo tablets. Competing interests The author(s) declare that they have no competing interests. Authors' contributions KP had the idea. KP and HA planned and designed the study, organized and supervised the data collection and finalized the manuscript together. KP analysed data and wrote the first draft. Acknowledgements We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.

Document structure show

article-title	Magnesium treatment in alcoholics: a randomized clinical trial
body	Correction After publication of our work [1], we noticed that the magnesium (Mg) content of the trial tablets was inadvertently given as 250 mg. The correct content was 200 mg. Thus the first sentence under the subtitle "Intervention" should read: The patients received orally for 8 weeks either a daily dose of 400 mg of Mg tablets divided in two tablets (200 mg each) or matching placebo tablets. Competing interests The author(s) declare that they have no competing interests. Authors' contributions KP had the idea. KP and HA planned and designed the study, organized and supervised the data collection and finalized the manuscript together. KP analysed data and wrote the first draft.
sec	Correction After publication of our work [1], we noticed that the magnesium (Mg) content of the trial tablets was inadvertently given as 250 mg. The correct content was 200 mg. Thus the first sentence under the subtitle "Intervention" should read: The patients received orally for 8 weeks either a daily dose of 400 mg of Mg tablets divided in two tablets (200 mg each) or matching placebo tablets.
title	Correction
p	After publication of our work [1], we noticed that the magnesium (Mg) content of the trial tablets was inadvertently given as 250 mg. The correct content was 200 mg. Thus the first sentence under the subtitle "Intervention" should read: The patients received orally for 8 weeks either a daily dose of 400 mg of Mg tablets divided in two tablets (200 mg each) or matching placebo tablets.
sec	Competing interests The author(s) declare that they have no competing interests.
title	Competing interests
p	The author(s) declare that they have no competing interests.
sec	Authors' contributions KP had the idea. KP and HA planned and designed the study, organized and supervised the data collection and finalized the manuscript together. KP analysed data and wrote the first draft.
title	Authors' contributions
p	KP had the idea. KP and HA planned and designed the study, organized and supervised the data collection and finalized the manuscript together. KP analysed data and wrote the first draft.
back	Acknowledgements We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.
ack	Acknowledgements We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.
sec	Acknowledgements We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.
title	Acknowledgements
p	We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.

projects that have annotations to this span

There is no project

TAB JSON ListView MergeView

PMC:2265677 / 774-1090 JSONTXT

Document structure show

projects that have annotations to this span

PMC:2265677 / 774-1090 JSON TXT